Concepedia

G. Bilger

GB

Statistics

Publications

4

Citations

137

H-Index

4

Active since

2020

Affiliations

Institut Curie(Current)

Université Paris-Saclay

Centre Hospitalier Universitaire de Grenoble

Hôpital Ambroise-Paré

Université de Versailles Saint-Quentin-en-Yvelines

G. Bilger is an author at Institut Curie specializing in lung cancer, medicine, and oncology.

Publications per year

2020–2022

4

Publications

4

Characteristics and Outcome of SARS-CoV-2 Infection in Cancer Patients

Clémence Basse, Sarah Diakite, Vincent Servois et al. · JNCI Cancer Spectrum · 2020 · 60 citations · Full text

Medicine, Infectious Diseases, Molecular Oncology +10

Discontinuation of immune checkpoint inhibitor (ICI) above 18 months of treatment in real-life patients with advanced non-small cell lung cancer (NSCLC): INTEPI, a multicentric retrospective study

G. Bilger, Nicolas Girard, H. Doubre et al. · Cancer Immunology Immunotherapy · 2021 · 44 citations · Full text

Medicine, Immunology, Oncology +17

Characteristics and outcome of SARS-CoV-2 infection in cancer patients.

Clémence Basse, Sarah Diakite, Vincent Servois et al. · medRxiv · 2020 · 18 citations · Full text

Medicine, Infectious Diseases, Oncology +13

Paclitaxel–bevacizumab combination in advanced non-squamous non-small-cell lung cancer (NSCLC): AVATAX, a retrospective multicentric study

G. Bilger, Anne‐Claire Toffart, Marie Darrason et al. · Therapeutic Advances in Medical Oncology · 2022 · 15 citations · Full text

Medicine, Oncology, Pharmacology +16

1–4 of 4